Nicola Gianotti - Dissemin

Language
Login

All papers authored by Nicola Gianotti

This paper was not found in any repository, but could be made available legally by the author.

2019 Sara Modica, David Redi, Roberta Gagliardini, Emanuela Giombini

ORCID

, Antonia Bezenchek, Domenico Di Carlo, Franco Maggiolo, Francesca Lombardi, Alberto Borghetti, Damiano Farinacci, Annapaola Callegaro, Maria R. Gismondo, Manuela Colafigli, Gaetana Sterrantino

ORCID

, Andrea Costantini and 6 other authors

Impact of NRTI resistance mutations on virological effectiveness of antiretroviral regimens containing elvitegravir: a multi-cohort study

Upload

This paper is made freely available by the publisher.

Nicola Gianotti

ORCID

, Patrizia Lorenzini, Alessandro Cozzi-Lepri, Andrea De Luca, Giordano Madeddu, Laura Sighinolfi, Carmen Santoro, Carmela Pinnetti, Cristina Mussini, Andrea Antinori, Paola Meraviglia, A. d’Arminio Monforte, Antonella d'Arminio Monforte, M. Andreoni, Antonella d’Arminio Monforte and 141 other authors

Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL

Download from academic.oup.com

This paper is made freely available by the publisher.

Andrea Antinori, S. Rusconi

ORCID

, N. Gianotti

ORCID

, T. Bini, D. Mancusi

ORCID

ORCID

Cardiovascular adverse events during treatment with darunavir-based regimens in an Italian observational study

Download from doi.org

This paper is made freely available by the publisher.

Vincenzo Spagnuolo

ORCID

, Laura Galli, Andrea Poli, Alba Bigoloni, Luca Fumagalli, Nicola Gianotti

ORCID

, Silvia Nozza, Davide Ferrari, Massimo Locatelli, Adriano Lazzarin, Antonella Castagna

A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: the DOLATAV study

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2018 Nicola Gianotti

ORCID

, Laura Galli, Nadia Galizzi, Marco Ripa, Andrea Andolina, Silvia Nozza, Vincenzo Spagnuolo, Andrea Poli, Adriano Lazzarin, Antonella Castagna

Time spent with residual viraemia after virological suppression below 50 HIV-RNA copies/mL according to type of first-line antiretroviral regimen

Upload

This paper is made freely available by the publisher.

2017 Nicola Gianotti

ORCID

, Andrea Poli, Silvia Nozza, Laura Galli, Nadia Galizzi, Marco Ripa, Marco Merli

ORCID

, Alessia Carbone, Vincenzo Spagnuolo, Adriano Lazzarin, Antonella Castagna

Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients

Download from doi.org

This paper is made freely available by the publisher.

Nicola Gianotti

ORCID

, Andrea Poli, Laura Galli, Michela Franzin, Patrizia Tadini, Nadia Galizzi, Alessia Carbone, Marco Merli

ORCID

, Camilla Muccini, Chiara Oltolini, Andrea Andolina, Vincenzo Spagnuolo, Adriano Lazzarin, Antonella Castagna

Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients

Download from doi.org

This paper is available in a repository.

Nicola Gianotti

ORCID

, Antonella d’Arminio Monforte, Jason F. Okulicz, Alessandro Cozzi-Lepri, Andrea Antinori, Antonella Castagna, Andrea De Luca, Benedetto Maurizio Celesia, Massimo Galli, Cristina Mussini, Carmela Pinnetti, Vincenzo Spagnuolo, Antonella d’Arminio Monforte, Francesca Ceccherini-Silberstein, Massimo Andreoni

Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients

Download from doi.org

Missing publications? Search for publications with a matching author name.